Health insurer Cigna Corp's Evernorth unit would partner with Kaiser Permanente to help patients enrolled in some its rival's health plans gain access to doctors while traveling.
Alembic Pharmaceuticals Limited today announced that it has received tentative approval from the US Food & Drug Administration for its Abbreviated New Drug Application (ANDA) for Ivabradine tablets, 5 mg and 7.5 mg.
Sanofi India Limited told that its Board of Directors has appointed Rodolfo Hrosz as the Company’s new Managing Director with effect from June 1, 2022, subject to regulatory approvals. He will transition from being Sanofi’s General Manager...
Phase 3 clinical trials of new breast cancer treatment approved in the U.S. and Europe will be conducted in Korea.
A Japanese Health Ministry committee said on Monday it has approved Novavax Inc's COVID-19 vaccine, setting the stage for full approval of the country's fourth shot for the coronavirus.
Biocon Biologics, a unit of Biocon, is raising $1.2 billion via an offshore loan with the pharmaceutical company likely appointing HSBC, MUFG and Standard Chartered Bank to underwrite the proposed five-year overseas loan, two sources familiar...
OcugenInc and Bharat Biotech declared that they have entered into an amendment to their co-development, supply and commercialisation agreement to expand Ocugen’s exclusive territory to include commercialisation of Covaxin in Mexico.
The Competition Commission of India approves acquisition of minority stake of BDR Pharmaceuticals International Private Limited (BDR/Target) by Multiples Private Equity Fund III, SRF Transnational Holdings Limited (SRF Transnational)...
QOL Medical, LLC, a ground-breaking rare disease pharmaceutical firm, has selected Optum Frontier Therapies as its new pharmacy partner to support CSID patients nationwide being treated with Sucraid (sacrosidase) oral solution.
COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical trials in Hong Kong, the firms said on Saturday.